Clinical Trial Results:
EFFICACY AND SAFETY OF ESLICARBAZEPINE ACETATE (BIA 2-093)
AS THERAPY FOR PATIENTS WITH PAINFUL DIABETIC NEUROPATHY:
A DOUBLE-BLIND, DOUBLE-DUMMY, RANDOMISED, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTRE CLINICAL TRIAL
Summary
|
|
EudraCT number |
2007-002461-12 |
Trial protocol |
PT HU CZ AT SK DE |
Global completion date |
25 Mar 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
08 Apr 2016
|
First version publication date |
16 Jul 2015
|
Other versions |
|
Summary report(s) |
BIA-2093-206 Synopsis BIA-2093-206 Open-Label Extension_Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.